Insider Activity of Ocumension Therapeutics
According to the SEC Form 4 filings, Ocumension Therapeutics, being in a position of
- director at EyePoint Pharmaceuticals, Inc.,оver the last 12 months, has bought 0 shares, and sold 1910500 shares for $37.16M,over all time since 2023-12-05, has bought 0 shares, and sold 2910500 shares for $56.67M.
The largest sale of all time was on 2024-01-11 and amounted to 1910500 shares of EyePoint Pharmaceuticals, Inc. for $37.16M.
Biography of Ocumension Therapeutics
No biography is available at this moment.